Advertisement

Management of Allergic Skin Disorders in Pregnancy

Published:October 27, 2022DOI:https://doi.org/10.1016/j.iac.2022.05.012

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Immunology and Allergy Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Research CfDEa
        PLLR labeling final rule. U.S. food and drug administration.
        (Available at:) (Accessed October 1, 2021)
        • Vestergaard C.
        • Wollenberg A.
        • Barbarot S.
        • et al.
        European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period.
        J Eur Acad Dermatol Venereol. 2019; 33: 1644-1659
        • Nassau S.
        • Fonacier L.
        Allergic contact dermatitis.
        Med Clin North Am. 2020; 104: 61-76
        • Zuberbier T.
        • Aberer W.
        • Asero R.
        • et al.
        The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
        Allergy. 2018; 73: 1393-1414
        • Saini S.
        • Shams M.
        • Bernstein J.A.
        • et al.
        Urticaria and angioedema across the ages.
        J Allergy Clin Immunol Pract. 2020; 8: 1866-1874
        • Saini S.
        • Rosen K.E.
        • Hsieh H.J.
        • et al.
        A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
        J Allergy Clin Immunol. 2011; 128: 567-573.e1
        • Grattan C.E.
        • O'Donnell B.F.
        • Francis D.M.
        • et al.
        Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.
        Br J Dermatol. 2000; 143: 365-372
        • Napolitano M.
        • Ruggiero A.
        • Fontanella G.
        • et al.
        New emergent therapies for atopic dermatitis: a review of safety profile with respect to female fertility, pregnancy, and breastfeeding.
        Dermatol Ther. 2021; 34: e14475
        • Mian M.
        • Dunlap R.
        • Simpson E.
        Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report.
        JAAD Case Rep. 2020; 6: 1051-1052
        • Kanda N.
        • Hoashi T.
        • Saeki H.
        The roles of sex hormones in the course of atopic dermatitis.
        Int J Mol Sci. 2019; 20https://doi.org/10.3390/ijms20194660
        • Weatherhead S.
        • Robson S.C.
        • Reynolds N.J.
        Eczema in pregnancy.
        BMJ. 2007; 335: 152-154
        • Gonzalez-Estrada A.
        • Geraci S.A.
        Allergy medications during pregnancy.
        Am J Med Sci. 2016; 352: 326-331
        • Tuttle KLF J.
        • Beck L.A.
        Novel systemic treatments in atopic dermatitis: are there sex differences?.
        Int J Women’s Dermatol. 2021; 7: 606-614
        • Rakita U.
        • Kaundinya T.
        • Silverberg J.I.
        Lack of association between atopic dermatitis severity and worsening during pregnancy: a cross-sectional study.
        J Am Acad Dermatol. 2021; https://doi.org/10.1016/j.jaad.2021.09.066
        • Hamann C.R.
        • Egeberg A.
        • Wollenberg A.
        • et al.
        Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark.
        J Eur Acad Dermatol Venereol. 2019; 33: 577-587
        • Murase J.E.
        • Heller M.M.
        • Butler D.C.
        Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
        J Am Acad Dermatol. 2014; 70 (quiz 415): 401.e1-14
        • Reitamo S.
        • Wollenberg A.
        • Schöpf E.
        • et al.
        Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European tacrolimus ointment study group.
        Arch Dermatol. 2000; 136: 999-1006
        • Draelos Z.
        • Nayak A.
        • Pariser D.
        • et al.
        Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
        J Am Acad Dermatol. 2005; 53: 602-609
        • Cartron A.M.
        • Nguyen T.H.
        • Roh Y.S.
        • et al.
        Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
        Clin Exp Dermatol. 2021; 46: 820-824
        • Dadashi M.
        • Hajikhani B.
        • Darban-Sarokhalil D.
        • et al.
        Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis.
        J Glob Antimicrob Resist. 2020; 20: 238-247
        • El-Saie L.T.
        • Rabie A.R.
        • Kamel M.I.
        • et al.
        Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis.
        Lasers Med Sci. 2011; 26: 481-485
        • Akbari M.
        • Shah S.
        • Velayos F.S.
        • et al.
        Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
        Inflamm Bowel Dis. 2013; 19: 15-22
        • Simons F.E.
        • Simons K.J.
        Histamine and H1-antihistamines: celebrating a century of progress.
        J Allergy Clin Immunol. 2011; 128 (e4): 1139-1150
        • Lobo Y.
        • Lee R.C.
        • Spelman L.
        Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature.
        Case Rep Dermatol. 2021; 13: 248-256
        • Wollenberg A.
        • Blauvelt A.
        • Guttman-Yassky E.
        • et al.
        Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
        Br J Dermatol. 2021; 184: 437-449
        • Zuberbier T.
        • Abdul Latiff A.H.
        • Abuzakouk M.
        • et al.
        The International EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
        Allergy. 2021; https://doi.org/10.1111/all.15090
        • Kolkhir P.
        • Borzova E.
        • Grattan C.
        • et al.
        Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review.
        Autoimmun Rev. 2017; 16: 1196-1208
        • Kocatürk E.
        • Al-Ahmad M.
        • Krause K.
        • et al.
        Effects of pregnancy on chronic urticaria: results of the PREG-CU UCARE study.
        Allergy. 2021; 76: 3133-3144
        • Fricke J.
        • Ávila G.
        • Keller T.
        • et al.
        Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis.
        Allergy. 2020; 75: 423-432
        • Zhong H.
        • Song Z.
        • Chen W.
        • et al.
        Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study.
        Allergy. 2014; 69: 359-364
        • Maurer M.
        • Ortonne J.P.
        • Zuberbier T.
        Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients.
        Br J Dermatol. 2009; 160: 633-641
        • Gregoriou S.
        • Rigopoulos D.
        • Katsambas A.
        • et al.
        Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study.
        J Cutan Med Surg. 2009; 13: 198-203
        • Sánchez Borges M.
        • Tassinari S.
        • Flores A.
        [Epidemiologic features in patients with antihistamine-resistant chronic urticaria].
        Rev Alerg Mex. 2015; 62 (Características epidemiológicas en pacientes con urticaria crónica espontánea resistente al tratamiento con antihistamínicos): 279-286
        • Straesser M.D.
        • Oliver E.
        • Palacios T.
        • et al.
        Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria.
        J Allergy Clin Immunol Pract. 2018; 6: 1386-1388.e1
        • Pierdominici M.
        • Maselli A.
        • Colasanti T.
        • et al.
        Estrogen receptor profiles in human peripheral blood lymphocytes.
        Immunol Lett. 2010; 132: 79-85
        • Kay A.B.
        • Clark P.
        • Maurer M.
        • et al.
        Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.
        Br J Dermatol. 2015; 172: 1294-1302
        • Kay A.B.
        • Ying S.
        • Ardelean E.
        • et al.
        Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.
        Clin Exp Allergy. 2014; 44: 1053-1060
        • Giménez-Arnau A.M.
        • DeMontojoye L.
        • Asero R.
        • et al.
        The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells.
        J Allergy Clin Immunol Pract. 2021; 9: 2195-2208
        • Krasselt M.
        • Baerwald C.
        Sex, symptom severity, and quality of life in rheumatology.
        Clin Rev Allergy Immunol. 2019; 56: 346-361
        • Maurer M.
        • Eyerich K.
        • Eyerich S.
        • et al.
        Urticaria: Collegium Internationale Allergologicum (CIA) update 2020.
        Int Arch Allergy Immunol. 2020; 181: 321-333
        • Asero R.
        • Marzano A.V.
        • Ferrucci S.
        • et al.
        Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
        Clin Exp Immunol. 2020; 200: 242-249
        • Ying S.
        • Kikuchi Y.
        • Meng Q.
        • et al.
        TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.
        J Allergy Clin Immunol. 2002; 109: 694-700
        • Shakouri A.
        • Compalati E.
        • Lang D.M.
        • et al.
        Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system.
        Curr Opin Allergy Clin Immunol. 2010; 10: 362-369
        • Robertson S.A.
        • Care A.S.
        • Moldenhauer L.M.
        Regulatory T cells in embryo implantation and the immune response to pregnancy.
        J Clin Invest. 2018; 128: 4224-4235
        • Murase J.E.
        • Chan K.K.
        • Garite T.J.
        • et al.
        Hormonal effect on psoriasis in pregnancy and post partum.
        Arch Dermatol. 2005; 141: 601-606
        • Woidacki K.
        • Zenclussen A.C.
        • Siebenhaar F.
        Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?.
        Front Immunol. 2014; 5: 231
        • Cocchiara R.
        • Albeggiani G.
        • Di Trapani G.
        • et al.
        Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens.
        Int Arch Allergy Appl Immunol. 1990; 93: 192-197
        • Woidacki K.
        • Popovic M.
        • Metz M.
        • et al.
        Mast cells rescue implantation defects caused by c-kit deficiency.
        Cell Death Dis. 2013; 4: e462
        • Zaitsu M.
        • Narita S.
        • Lambert K.C.
        • et al.
        Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx.
        Mol Immunol. 2007; 44: 1977-1985
        • Narita S.
        • Goldblum R.M.
        • Watson C.S.
        • et al.
        Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators.
        Environ Health Perspect. 2007; 115: 48-52
        • Kasperska-Zajac A.
        • Brzoza Z.
        • Rogala B.
        Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria.
        Allergy. 2006; 61: 1489-1490
        • Choi I.S.
        • Cui Y.
        • Koh Y.A.
        • et al.
        Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics.
        Korean J Intern Med. 2008; 23: 176-181
        • Lawlor F.
        Urticaria and angioedema in pregnancy and lactation.
        Immunol Allergy Clin N Am. 2014; 34: 149-156
        • Beissert S.
        • Ständer H.
        • Schwarz T.
        UVA rush hardening for the treatment of solar urticaria.
        J Am Acad Dermatol. 2000; 42: 1030-1032
        • Kowalski M.L.
        • Woessner K.
        • Sanak M.
        Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
        J Allergy Clin Immunol. 2015; 136: 245-251
        • Powell R.J.
        • Leech S.C.
        • Till S.
        • et al.
        BSACI guideline for the management of chronic urticaria and angioedema.
        Clin Exp Allergy. 2015; 45: 547-565
        • Bousquet J.
        • Khaltaev N.
        • Cruz A.A.
        • et al.
        Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).
        Allergy. 2008; 63: 8-160
        • Viegas L.P.
        • Ferreira M.B.
        • Kaplan A.P.
        The maddening itch: an approach to chronic urticaria.
        J Investig Allergol Clin Immunol. 2014; 24: 1-5
        • Maurer M.
        • Altrichter S.
        • Bieber T.
        • et al.
        Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
        J Allergy Clin Immunol. 2011; 128 (e5): 202-209
        • Metz M.
        • Vadasz Z.
        • Kocatürk E.
        • et al.
        Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence.
        Clin Rev Allergy Immunol. 2020; 59: 38-45
        • Vena G.A.
        • Cassano N.
        • Colombo D.
        • et al.
        Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
        J Am Acad Dermatol. 2006; 55: 705-709
        • Zuberbier T.
        • Iffländer J.
        • Semmler C.
        • et al.
        Acute urticaria: clinical aspects and therapeutic responsiveness.
        Acta Derm Venereol. 1996; 76: 295-297
        • Zuberbier T.
        A summary of the new International EAACI/GA2LEN/EDF/WAO guidelines in urticaria.
        World Allergy Organ J. 2012; 5: S1-S5
        • Zuberbier T.
        Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
        J Eur Acad Dermatol Venereol. 2012; 26: 9-18
        • Powell R.J.
        • Du Toit G.L.
        • Siddique N.
        • et al.
        BSACI guidelines for the management of chronic urticaria and angio-oedema.
        Clin Exp Allergy. 2007; 37: 631-650
        • Akenroye A.T.
        • McEwan C.
        • Saini S.S.
        Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria.
        J Allergy Clin Immunol Pract. 2018; 6: 1403-1405
        • Kaplan A.
        • Ledford D.
        • Ashby M.
        • et al.
        Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
        J Allergy Clin Immunol. 2013; 132: 101-109
        • Bundhoo A.
        • Paveglio S.
        • Rafti E.
        • et al.
        Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.
        Clin Exp Allergy. 2015; 45: 1085-1098
        • Namazy J.A.
        • Blais L.
        • Andrews E.B.
        • et al.
        Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.
        J Allergy Clin Immunol. 2020; 145: 528-536.e1
        • Fonacier L.
        • Bernstein D.I.
        • Pacheco K.
        • et al.
        Contact dermatitis: a practice parameter-update 2015.
        J Allergy Clin Immunol Pract. 2015; 3: S1-S39
        • Mowad C.M.
        • Anderson B.
        • Scheinman P.
        • et al.
        Allergic contact dermatitis: patient diagnosis and evaluation.
        J Am Acad Dermatol. 2016; 74: 1029-1040